Search results
Results from the WOW.Com Content Network
Choriocarcinoma is a malignant, trophoblastic [1] cancer, usually of the placenta. It is characterized by early hematogenous spread to the lungs. It is characterized by early hematogenous spread to the lungs.
[7] [9] Rates are lower in the developing than the developed world. [10] Onset most commonly occurs in males 20 to 34 years old, rarely before 15 years old. [3] [11] The five-year survival rate in the United States is about 95%. [3] Outcomes are better when the disease remains localized. [3]
In males, researchers suggest that the overall reduction in cancer death rates is due in large part to a reduction in tobacco use over the last half century, estimating that the reduction in lung cancer caused by tobacco smoking accounts for about 40% of the overall reduction in cancer death rates in men and is responsible for preventing at least 146,000 lung cancer deaths in men during the ...
Adjusting for these and other factors, survival was 60% higher for men treated in a cancer unit that treated the majority of these men, though the unit treated more men with the worst prognosis. [19] Choriocarcinoma of the testicles has the worst prognosis of all germ-cell cancers. [20]
In the United States during 2013–2017, the age-adjusted mortality rate for all types of cancer was 189.5/100,000 for males, and 135.7/100,000 for females. [1] Below is an incomplete list of age-adjusted mortality rates for different types of cancer in the United States from the Surveillance, Epidemiology, and End Results program.
Five-year survival rates can be used to compare the effectiveness of treatments. Use of five-year survival statistics is more useful in aggressive diseases that have a shorter life expectancy following diagnosis, such as lung cancer , and less useful in cases with a long life expectancy, such as prostate cancer .
A DAY IN THE LIFE OF A DOMESTIC WORKER: CARIBBEAN IMMIGRANT WOMEN AND THE CAMPAIGN FOR FAIR LABOR STANDARDS (with related Policy Recommendations) By ARLENE M. ROBERTS, ESQ.
A retrospective study of 83 women with sex cord–stromal tumours (73 with granulosa cell tumour and 10 with Sertoli-Leydig cell tumour), all diagnosed between 1975 and 2003, reported that survival was higher with age under 50, smaller tumour size, and absence of residual disease. The study found no effect of chemotherapy. [13]